Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections

BACKGROUND: Levofloxacin 0.5% ophthalmic solution is an antibacterial formulation, which was approved and marketed for the treatment of ocular infections in Japan in 2000. OBJECTIVE: This study was designed to investigate the safety and efficacy of levofloxacin 0.5% ophthalmic solution in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Yoshiko, Kayama, Tomoko, Okamoto, Shinji, Hashimoto, Masako, Ishida, Chiemi, Yanai, Tomoko, Fukumoto, Mitsuru, Kunihiro, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586049/
https://www.ncbi.nlm.nih.gov/pubmed/23075336
http://dx.doi.org/10.2165/11636020-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586049/
https://www.ncbi.nlm.nih.gov/pubmed/23075336
http://dx.doi.org/10.2165/11636020-000000000-00000

Ejemplares similares